USD 478.53 million
Platelet Rich Plasma Market Size, Share, Growth Analysis, By Type (Pure Platelet Rich Plasma (P-PRP), Leukocyte-Rich Platelet Rich Plasma (L-PRP)), By Origin (Autologous PRP, Allogeneic PRP), By Application, By End-User, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2097 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
116
|Figures:
77
Platelet Rich Plasma Market Insights
Platelet Rich Plasma Market size was valued at USD 629.19 Million in 2023 and is poised to grow from USD 699.34 Million in 2024 to USD 2481.47 Million by 2032, growing at a CAGR of 11.15% during the forecast period (2025-2032).
Injections of platelet-rich plasma (PRP) are becoming more and more popular for treating a range of ailments, including hair loss and sports injuries. A patient's own blood cells are used in the procedure to hasten the healing of a particular area. Many musculoskeletal injuries and conditions may be treated with PRP injections. For instance, adding PRP injections to a treatment plan can help to speed up the healing process, lessen pain, and enable a quicker return to activities for chronic tendon injuries like tennis elbow or jumper's knee. Prospects for extensive medical study have been opened up by the growing use of platelet-rich plasma in surgical and regenerative therapy treatments. This will drive demand in the market along with an increase in the frequency of sports-related injuries, oral and maxillofacial procedures, and periodontal surgery.
US Platelet Rich Plasma Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Pure Platelet Rich Plasma
Fastest Growth
Pure Platelet Rich Plasma
Growth Rate
12.8% CAGR
Global Platelet Rich Plasma Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Platelet Rich Plasma Market Segmental Analysis
Global Platelet Rich Plasma Market is segmented by type, origin, application, by end-user and region. Based on type, the market is segmented into pure platelet rich plasma (P-PRP), leukocyte-rich platelet rich plasma (L-PRP), leukocyte-rich fibrin (L-PRF) and others. Based on origin, the market is segmented into autologous PRP, allogeneic PRP and homologous PRP. Based on application, the market is segmented into orthopedic and spinal surgery, cosmetic surgery and aesthetics, general surgery, neurosurgery and others. Based on end-user, the market is segmented into hospitals and clinics, research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Platelet Rich Plasma Market Analysis by Type
Pure Platelet rich plasma segment accounted for the largest market share in 2021. This can be explained on account of its vast application in tissue repair, regeneration, and the healing process. Due to allergic and immunological reactions during treatments, PRP has the least amount of danger and side effects. Manufacturers are eager to create new goods because the market is mostly renowned for its off-label use and is anticipated to increase. The use of pure PRP in a variety of circumstances and the high platelet concentration, both of which are anticipated to accelerate the segment's growth over the next few years. The development of technology, including smart home diagnostic kits, has boosted the global market.
During the projection period, the leucocyte-rich segment is anticipated to see the quickest CAGR of above 15% approximately during the forecast period owing to general surgery, orthopaedics, and sports injuries, where its usefulness is growing. It has been proven via evidence that Leucocyte-Rich Platelet rich plasma is helpful in bone regeneration and the non-surgical therapy of knee osteoarthritis, which is expected to drive market expansion over the forecast period.
Platelet Rich Plasma Market Analysis by Application
The segment for orthopedics held the largest market share in 2021. The most prevalent orthopaedic conditions are osteoarthritis (OA) and cartilage abnormalities, in which articular cartilage deterioration results in joint damage. Orthopedists have a problem when treating severely injured articular cartilage and bone abnormalities since it might be difficult to locate a suitable bone substitute and cartilage has a limited capacity for regeneration. With its high concentration of growth factors in cells, PRP is emerging as a helpful therapy option for this condition since it sped up the regeneration of arthritic cartilage. PRP also increases the activity of low-level cells, and the procedure is simple, inexpensive, and safe for patients' health. These elements are encouraging platelet-rich plasma uses in orthopaedics, which is promoting market expansion.
During the projected period, it is expected that dermatology applications segment would increase at a high rate. This can be attributed to plastic surgery and its growing application in ulcer therapy. Platelet-rich plasma is used in plastic surgery for treatments including fat grafting, laser therapy, removing acne scars, alopecia, and skin rejuvenation. One of the main application areas for these is skin rejuvenation for aged face skin since PRP stimulates collagen formation and helps reconstruct the extracellular matrix. The market demand for PRP-based microneedling in cosmetic operations has fueled market growth expectations. Treatment with PRP for chronic ulcers shrinks the ulcer and totally cures the ulcer wounds.
Global Platelet Rich Plasma Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Platelet Rich Plasma Market Regional Insights
North America dominated the Global Platelet Rich Plasma Market share in 2021. This may be ascribed to the existence of several production facilities eager to create innovative PRP-based treatment methods, the high procurement at end-users including hospitals and clinics, and the presence of significant market participants. The market presence was reinforced by the assistance and approvals given by regulatory bodies. Such actions are predicted to increase market availability of platelet-rich plasma and speed up growth. During the projected period, it is predicted that the U.S. would provide promising growth opportunities. In the nation, PRP-based therapies are extensively used, with an increase in orthopaedic and aesthetic operations. The prominence of major players in the U.S together with the developed healthcare system in the nation, will also continue to influence the demand prognosis for platelet-rich plasma over the evaluation period. Due to these developments, the industry is anticipated to have a 3/10th market share.
Asia Pacific is anticipated to grow at a high growth rate during the forecast period owing to the sizable patient population suffering from a wide range of rheumatic illnesses, rise in the number of sports injury cases, and development in the demand for aesthetic surgery in developing nations like India and China. Additionally, the increase in cosmetic surgery procedures, the rise in interest in academic and research institutions, and the expansion of government funding for healthcare innovations is expected to boost market growth in this region.
Global Platelet Rich Plasma Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Platelet Rich Plasma Market Dynamics
Platelet Rich Plasma Market Driver
- The use of platelet-rich plasma in the treatment of orthopaedic diseases, musculoskeletal ailments, and sports injuries has seen a surge in demand. It focuses on growth factors and can speed up healing considerably. PRP is a significant source of personalised products for each patient in the field of regenerative medicine, supporting the cascade of wound healing and tissue restoration. These factors positively affect the market growth.
- Promising outcomes of PRP include wound healing, bone formation in osteonecrosis of the jaw caused by bisphosphonates, and soft tissue healing in the alveolar socket following tooth extraction. Additionally, it is anticipated that medical factors will create a number of therapeutic expansion opportunities, propelling the market in the future.
- Platelet-rich plasma is used in plastic surgery for treatments including fat grafting, laser therapy, removing acne scars, alopecia, and skin rejuvenation. One of the main application areas for these is skin rejuvenation for aged face skin since PRP stimulates collagen formation and helps reconstruct the extracellular matrix. Due to the increasing number of applications for PRP, the market is expected to develop.
Platelet Rich Plasma Market Restraint
- The predicted expansion of the platelet rich plasma market in the targeted period would be hampered by the rising volatilization of the price of platelet-rich plasma therapy. The expansion of the market, however, may soon be further hampered by issues with quality control and test findings. Also, official FDA approval required in cases of end-use impedes market expansion.
Request Free Customization of this report to help us to meet your business objectives.
Platelet Rich Plasma Market Competitive Landscape
Global Platelet Rich Plasma Market is moderately competitive. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. Major Players include Johnson & Johnson, Arthrex, Inc., EmCyte Corporation and DR. PRP AMERICA, LLC. among others. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.
Platelet Rich Plasma Market Top Player's Company Profiles
- Harvest Technology (USA)
- Stryker Corporation (USA)
- Zimmer Biomet (USA)
- Arthrex Inc. (USA)
- Terumo BCT Inc. (USA)
- Celling BioSciences Inc. (USA)
- APEX Biologix (USA)
- Juventix Regenerative Medical, LLC (Italy)
- Dr. PRP USA LLC (USA)
- Ycellbio Medical Co., Ltd. (South Korea)
- EmCyte Corporation (USA)
- Regen Lab SA (Switzerland)
- Zimmer Biomet (USA)
- Arthrex Inc. (USA)
- Terumo BCT Inc. (USA)
- Celling BioSciences Inc. (USA)
Platelet Rich Plasma Market Recent Developments
- In November 2022, Tri-Cities Infusion & Wellness Clinic, PLLC, which is based in Kennewick, Washington, has signed an agreement to sell its assets to Irwin Naturals Inc. Infusions of ketamine, which have been used to treat a number of mental disorders, are available at the clinic. Additionally, it provides regenerative therapies including platelet-rich plasma (PRP) injections, cosmetic procedures, and IV nutrition infusions.
- In September 2022, Suneva Medical, Inc.'s launched its Amplifine Platelet Rich Plasma (PRP) gel tubes 30ml version which will give patients and practises a larger volume of PRP to address various areas of concern more effectively. Suneva Medical, Inc. is a cutting-edge medical technology company that uses regenerative products to change the standard of care in patient treatments. The U.S. Food and Drug Administration (FDA) granted the 30 mL PRP tubes 510(k) certification earlier this year.
Platelet Rich Plasma Key Market Trends
- Human dermal cells that control hair follicle development are successfully multiplied by platelet-rich plasma. PRP has led to an overall rise in hair density, which is driving demand in the market both as a stand-alone treatment and in combination with hair transplant procedures. Given that PRP is an autologous product, it is thought to be safe and devoid of infectious infections. No major post-treatment adverse effects have been reported, however mild side effects including bruising, erythema, and crusting are thought to be rather prevalent. Researchers have discovered proof that PRP can stimulate fresh hair growth. To determine if PRP is efficient, however, further study is required because to the drawbacks of these trials, including as their small sample numbers and the variations in technique and procedure across physicians. The best PRP candidates must be found, and standardised treatment methods must be developed by medical professionals and researchers.
Platelet Rich Plasma Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our Global Platelet Rich Plasma Market analysis, the use of platelet-rich plasma (PRP) has increased across diverse fields of medicine including dermatologic, oral, and maxillofacial procedures. Skin rejuvenation for aging facial skin is one of the key segments for applications as PRP induces collagen synthesis and assists remodeling of the extracellular matrix. PRP has also emerged as a popular alternative for botox treatments, which is facilitating the demand for PRP kits and products. PRP is increasingly finding applications in surgical and non-surgical procedures including treatment of tendon injuries, cartilage damage, bone pathologies, muscle trauma, and wound healing. PRP stimulates low cell activity and the technique is affordable while having no side effects and danger to the patients' health. These application are positively impacting market growth.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 478.53 million |
| Market size value in 2031 | USD 1414.79 million |
| Growth Rate | 12.8% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Platelet Rich Plasma Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Platelet Rich Plasma Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Platelet Rich Plasma Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Platelet Rich Plasma Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Platelet Rich Plasma Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Platelet Rich Plasma Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
